Capital Counsel’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,750
| Closed | -$329K | – | 53 |
|
|
2023
Q3 | $329K | Sell |
4,750
-1,100
| -19% | -$76.2K | 0.02% | 41 |
|
|
2023
Q2 | $552K | Buy |
5,850
+1,100
| +23% | +$104K | 0.03% | 34 |
|
|
2023
Q1 | $393K | Sell |
4,750
-700
| -13% | -$57.9K | 0.02% | 38 |
|
|
2022
Q4 | $407K | Sell |
5,450
-825,854
| -99% | -$61.6M | 0.03% | 42 |
|
|
2022
Q3 | $68.7M | Buy |
831,304
+29,564
| +4% | +$2.44M | 4.45% | 10 |
|
|
2022
Q2 | $76.2M | Sell |
801,740
-262,179
| -25% | -$24.9M | 4.65% | 10 |
|
|
2022
Q1 | $125M | Buy |
1,063,919
+227,722
| +27% | +$26.8M | 5.95% | 9 |
|
|
2021
Q4 | $108M | Buy |
836,197
+479,749
| +135% | +$62.2M | 4.59% | 11 |
|
|
2021
Q3 | $40.4M | Buy |
+356,448
| New | +$40.4M | 1.99% | 13 |
|